Follow
Robert L Obenchain
Robert L Obenchain
Principal, Risk Benefit Statistics, CA 94517
No verified email - Homepage
Title
Cited by
Cited by
Year
Factors associated with women's decisions to seek treatment for urinary incontinence
KS Kinchen, K Burgio, AC Diokno, NH Fultz, R Bump, R Obenchain
Journal of women's health 12 (7), 687-698, 2003
3732003
Burden of stress urinary incontinence for community-dwelling women
NH Fultz, K Burgio, AC Diokno, KS Kinchen, R Obenchain, RC Bump
American journal of obstetrics and gynecology 189 (5), 1275-1282, 2003
3192003
Analysis of observational health care data using SAS
DE Faries, AC Leon, JM Haro, RL Obenchain
SAS Institute, 2010
2372010
Medical and self-care practices reported by women with urinary incontinence
AC Diokno, K Burgio, NH Fultz, KS Kinchen, R Obenchain, RC Bump
American Journal of Managed Care 10 (2; PART 1), 69-80, 2004
1332004
Item response analysis of the Positive and Negative Syndrome Scale
DA Santor, H Ascher-Svanum, JP Lindenmayer, RL Obenchain
Bmc Psychiatry 7, 1-10, 2007
1302007
Ridge analysis following a preliminary test of the shrunken hypothesis
RL Obenchain
Technometrics 17 (4), 431-441, 1975
1271975
Urinary incontinence in physically active young women: prevalence and related factors
JO Alves, ST Da Luz, S Brandão, CM Da Luz, RN Jorge, T Da Roza
International journal of sports medicine 38 (12), 937-941, 2017
1262017
Classical F-tests and confidence regions for ridge regression
RL Obenchain
Technometrics 19 (4), 429-439, 1977
1231977
Reliability, validity, and application of the medical outcomes study 36-item short-form health survey (SF-36) in schizophrenic patients treated with olanzapine versus haloperidol
SL Tunis, TW Croghan, DK Heilman, BM Johnstone, RL Obenchain
Medical Care 37 (7), 678-691, 1999
1161999
Effect ofantidepressant therapy on health care utilization and costs in primary care
TW Croghan, T Lair, L Engelhart, WE Crown, CA Meffi, RL Obenchain
therapy 48, 1420-6, 1997
1061997
Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims
RL Robinson, SR Long, S Chang, S Able, O Baser, R Obenchain, ...
Journal of Managed Care Pharmacy 12 (1), 43-54, 2006
912006
Determinants of antidepressant treatment outcome
N Sood, M Treglia, RL Obenchain, B Dulisse, CA Melfi, TW Croghan
American Journal of Managed Care 6 (12), 1327-1339, 2000
842000
Prevalence and outcomes of continence surgery in community dwelling women
AC Diokno, K Burgio, NH Fultz, KS Kinchen, R Obenchain, RC Bump
The Journal of urology 170 (2), 507-511, 2003
782003
What Does Treatment Of Depression Really Cost? Although treating a patient with depression is expensive, the bulk of the cost is for care of accompanying illnesses.
TW Croghan, RL Obenchain, WE Crown
Health Affairs 17 (4), 198-208, 1998
731998
The application of sample selection models to outcomes research: the case of evaluating the effects of antidepressant therapy on resource utilization
WH Crown, RL Obenchain, L Englehart, T Lair, DP Buesching, T Croghan
Statistics in medicine 17 (17), 1943-1958, 1998
701998
Good and optimal ridge estimators
RL Obenchain
The Annals of Statistics 6 (5), 1111-1121, 1978
641978
Bootstrap analyses of cost effectiveness in antidepressant pharmacotherapy
RL Obenchain, CA Melfi, TW Croghan, DP Buesching
PharmacoEconomics 11, 464-472, 1997
601997
Determinants of antidepressant treatment compliance: implications for policy
M Tai-Seale, TW Croghan, R Obenchain
Medical Care Research and Review 57 (4), 491-512, 2000
522000
Abciximab provides cost-effective survival advantage in high-volume interventional practice
DJ Kereiakes, RL Obenchain, BL Barber, A Smith, M McDonald, ...
American heart journal 140 (4), 603-610, 2000
442000
Hypothyroidism risk compared among nine common bipolar disorder therapies in a large US cohort
CG Lambert, AJ Mazurie, NR Lauve, NG Hurwitz, SS Young, ...
Bipolar disorders 18 (3), 247-260, 2016
432016
The system can't perform the operation now. Try again later.
Articles 1–20